| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/29/2009 | CN100518828C Prolonged release biodegradable microspheres and method for preparing same |
| 07/29/2009 | CN100518827C Controlled release hydrocodone formulations |
| 07/29/2009 | CN100518819C Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/29/2009 | CN100518779C Skeleton glue and its preparation method |
| 07/29/2009 | CN100518749C Medicine for treating oral exulceratio and periodontal turgescene, and preparation method thereof |
| 07/29/2009 | CN100518748C Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 07/29/2009 | CN100518737C Cilostazol solid agent |
| 07/29/2009 | CN100518727C Preparaton method of anticancer medicine colchicin microsphere freeze dried agent |
| 07/29/2009 | CN100518726C Pharmaceutical solutions of modafinil compounds |
| 07/29/2009 | CN100518725C Venlafaxine hydrochloride liquid slow-release preparation and its preparation method |
| 07/29/2009 | CN100518724C Drug releasing membrane controlled by program and its preparation method |
| 07/29/2009 | CN100518723C Composition for capsule film, capsule film, and capsule made with the same |
| 07/29/2009 | CN100518722C Wrapped tablets dichlororeytadin and its preparing method |
| 07/29/2009 | CN100518721C Enteric quick-dissolving tablets containing aconitine, and preparation method thereof |
| 07/29/2009 | CN100518720C Orally quick-acting tablet of ginseng stem leaf saponin including orally disintegrating tablet and dispersible tablet and method for preparing the same |
| 07/29/2009 | CN100518719C Method for preparing composite substrate multifunctional arterial embolic agent |
| 07/29/2009 | CN100518718C Preparation of powder agglomerates |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566742 phosphoprotein preparation comprises a partially cross-linked partial hydrolysate of casein; a source of calcium ions; and a source of phosphate ions, or a source of strontium ions; calcium phosphate |
| 07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 07/28/2009 | US7566705 Combination of formoterol and mometasone furoate for asthma |
| 07/28/2009 | US7566462 Storage stability; mixture of tetrahydrobiopterin and excipient |
| 07/28/2009 | US7566445 Canister comprising container closed with metering valve, comprising pharmaceutical suspension aerosol formulation free of surfactant, which consists of salbutamol sulphate, ethanol, and 1,1,1,2-tetrafluoroethane; higher levels of ethanol have beneficial results |
| 07/28/2009 | US7565905 Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness |
| 07/28/2009 | CA2505964C Pharmaceutical compositions and dosage forms of thalidomide |
| 07/28/2009 | CA2470747C Extended release pharmaceutical tablet of metformin |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/28/2009 | CA2432024C Label with thinning agent for natural airway secretions |
| 07/28/2009 | CA2408638C Method of producing structures using centrifugal forces |
| 07/28/2009 | CA2377174C Oral administration forms for administering a fixed tramadol and diclofenac combination |
| 07/28/2009 | CA2370067C Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 07/28/2009 | CA2245370C Production of pharmaceutical formulations for treatment of edema and venous disorders |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/24/2009 | CA2618953A1 Colloidosomes having tunable properties and methods for making colloidosomes having tunable properties |
| 07/23/2009 | WO2009092094A2 Method and device for repair of degenerative cartilage |
| 07/23/2009 | WO2009092002A1 Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| 07/23/2009 | WO2009091927A1 Ultrasonically active microparticles and method of use |
| 07/23/2009 | WO2009091894A1 Ophthalmic preparations |
| 07/23/2009 | WO2009091622A1 Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 07/23/2009 | WO2009091576A2 Parenteral formulations of dopamine agonists |
| 07/23/2009 | WO2009091531A2 Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery |
| 07/23/2009 | WO2009091346A2 Stable pharmaceutical formulation and preparation methods |
| 07/23/2009 | WO2009091050A1 Composition for oral application |
| 07/23/2009 | WO2009090962A1 Microparticle film composition |
| 07/23/2009 | WO2009090950A1 Chitosan-containing compositions and process for production thereof |
| 07/23/2009 | WO2009090558A2 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 07/23/2009 | WO2009090495A2 Oil and liquid silicone foamable carriers and formulations |
| 07/23/2009 | WO2009090484A2 Mesalazine tablet |
| 07/23/2009 | WO2009090189A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | WO2009090074A1 Film forming, silicone containing compositions |
| 07/23/2009 | WO2009090027A2 Carrier pellets, method for the production thereof and use thereof |
| 07/23/2009 | WO2009090020A1 Monolithic in-situ cross-linked alginate implants |
| 07/23/2009 | WO2009090009A1 Pharmaceutical formulation comprising an anticholinergic drug |
| 07/23/2009 | WO2009090008A1 Dry powder formulation comprising an anticholinergic drug |
| 07/23/2009 | WO2009089845A1 Agent for intra-articular injection |
| 07/23/2009 | WO2009089826A1 Benzodiazepine and/or pharmaceutical composition comprising benzodiazapine derivatives |
| 07/23/2009 | WO2009089822A2 Use of an acetylsalicylic acid salt for the treatment of viral infections |
| 07/23/2009 | WO2009089632A1 Implantable devices for promoting reendothelialization and methods of use thereof |
| 07/23/2009 | WO2009066182A3 Method of treating cancer |
| 07/23/2009 | WO2009065130A3 Modified release formulations of diltiazem |
| 07/23/2009 | WO2009064374A8 Oral formulations of bis(thiohydrazide amides) |
| 07/23/2009 | WO2009060077A3 Intrauterine deposit |
| 07/23/2009 | WO2009057138A3 Controlled release pharmaceutical compositions of tolterodine |
| 07/23/2009 | WO2009044118A3 Indelibly marked polymeric films |
| 07/23/2009 | WO2009043988A3 Method for producing stable powder compositions |
| 07/23/2009 | WO2009016358A3 Pharmaceutical compositions and process for making them |
| 07/23/2009 | WO2009001085A3 An inhalable composition comprising nicotine |
| 07/23/2009 | WO2008153762A3 S-nitrosothiol formulations and storage systems |
| 07/23/2009 | WO2008139170A3 Transdermal and transmucosal drug delivery enhancers |
| 07/23/2009 | WO2008116601A3 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 07/23/2009 | WO2008106689A3 Breakthrough pain management |
| 07/23/2009 | WO2008102264A3 Stable digestive enzyme compositions |
| 07/23/2009 | WO2008084504A3 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/23/2009 | WO2008055136A3 Liquid formulations of phospholipase enzyme inhibitors |
| 07/23/2009 | WO2005034861A3 A dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 07/23/2009 | US20090187167 Integrated intra-dermal delivery, diagnostic and communication system |
| 07/23/2009 | US20090186925 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 07/23/2009 | US20090186903 Aripiprazole complex formulation and method |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186856 Micronutrient phosphates as dietary and health supplements |
| 07/23/2009 | US20090186807 Zinc-free and low-zinc insulin preparations having improved stability |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 07/23/2009 | US20090186094 Injectable and Swellable Microspheres for Tissue Bulking |
| 07/23/2009 | US20090186093 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
| 07/23/2009 | US20090186092 System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same |
| 07/23/2009 | US20090186091 Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis |
| 07/23/2009 | US20090186090 Oral Care Composition to Reduce or Eliminate Dental Sensitivity |
| 07/23/2009 | US20090186089 non-porous film for culturing cells |
| 07/23/2009 | US20090186088 Inhalable drug |
| 07/23/2009 | US20090186087 Enteric sustained-release coated core and pharmaceutical dosage form and method for manufacturing the same |
| 07/23/2009 | US20090186086 Solid multilayer oral dosage forms |
| 07/23/2009 | US20090186085 Methods and Apparatus For Determining Formulation Orientation of Multi-Layered Pharmaceutical Dosage Forms |
| 07/23/2009 | US20090186084 Form of administration of racecadotril |
| 07/23/2009 | US20090186083 Method for stabilization of isoxazole compound |
| 07/23/2009 | US20090186082 Method of manufacturing modified release dosage forms |
| 07/23/2009 | US20090186081 Disintegrating Loadable Tablets |
| 07/23/2009 | US20090186080 Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products |
| 07/23/2009 | US20090186079 Oral and overall health by negating the biological effects of bacterial lipids |